FASEB J. Uncover Your Biological Pathway
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brockway, L. M.
Right arrow Articles by Furcht, L. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brockway, L. M.
Right arrow Articles by Furcht, L. T.
Related Collections
Right arrowRelated Articles
(The FASEB Journal. 2006;20:2435-2438.)
© 2006 FASEB

Conflicts of interest in biomedical research— the FASEB guidelines

Laura M. Brockway*,1 and Leo T. Furcht{dagger},2

* Senior Science Policy Analyst, Office of Public Affairs, Federation of American Societies for Experimental Biology (FASEB), Bethesda, Maryland, USA; and

{dagger} Allen-Pardee Professor and Head, Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, Minnesota, USA

1Correspondence: FASEB Office of Public Affairs, 9650 Rockville Pike, Bethesda, MD 20814-3998, USA. E-mail: lbrockway{at}faseb.org

The rise in academia-industry relationships has been accompanied by increasing concerns about financial conflicts of interest. To date, policy recommendations addressing financial conflicts of interest have focused on the role of academic institutions in reviewing and overseeing investigator relationships with industry. However, investigators as a group determine the effectiveness of policies and practices. Therefore, there is a clear need for a consensus statement of standards for academia-industry interactions from the scientists’ perspective. To meet that need, we propose conflict of interest guidelines for individual biomedical investigators to address the critical challenges faced when financial relationships with industry exist.—Brockway, L. M., Furcht, L. T. Conflicts of interest in biomedical research—the FASEB guidelines.


Key Words: industry • policy • consulting • scientists • integrity


Related Articles

Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin
Kelvin J. A. Davies, Gennady Ermak, Beverley A. Rothermel, Melanie Pritchard, Joseph Heitman, Joohong Ahnn, Flavio Henrique-Silva, Dana Crawford, Silvia Canaider, Pierluigi Strippoli, Paolo Carinci, Kyung-Tai Min, Deborah S. Fox, Kyle W. Cunningham, Rhonda Bassel-Duby, Eric N. Olson, Zhuohua Zhang, R. Sanders Williams, Hans-Peter Gerber, Mercè Pérez-Riba, Hisao Seo, Xia Cao, Claude B. Klee, Juan Miguel Redondo, Lois J. Maltais, Elspeth A. Bruford, Sue Povey, Jeffery D. Molkentin, Frank D. McKeon, Elia J. Duh, Gerald R. Crabtree, Martha S. Cyert, Susana de la Luna, and Xavier Estivill
FASEB J 2007 21: 3023-3028. [Full Text] [PDF]

Can medical schools teach high school students to be scientists?
James T. Rosenbaum, Tammy M. Martin, Kendra H. Farris, Richard B. Rosenbaum, and Edward A. Neuwelt
FASEB J 2007 21: 1954-1957. [Abstract] [Full Text] [PDF]

NASA—has its biological groundwork for a trip to Mars improved?
Francis J. Haddy
FASEB J 2007 21: 643-646. [Abstract] [Full Text] [PDF]

The science and ethics of making part-human animals in stem cell biology
Jason Scott Robert
FASEB J 2006 20: 838-845. [Abstract] [Full Text] [PDF]

N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation
Chiara Laezza, Maria Notarnicola, Maria Gabriella Caruso, Caterina Messa, Marco Macchia, Simone Bertini, Filippo Minutolo, Giuseppe Portella, Laura Fiorentino, Stefania Stingo, and Maurizio Bifulco
FASEB J 2006 20: 412-418. [Abstract] [Full Text] [PDF]

Research contribution of different world regions in the top 50 biomedical journals (1995–2002)
Elpidoforos S. Soteriades, Evangelos S. Rosmarakis, Konstantinos Paraschakis, and Matthew E. Falagas
FASEB J 2006 20: 29-34. [Abstract] [Full Text] [PDF]

ets-1 is transcriptionally up-regulated by H2O2 via an antioxidant response element
Leigh A. Wilson, Adam Gemin, Raissa Espiritu, and Gurmit Singh
FASEB J 2005 0: 05-4401fjev1-1111. [Abstract] [PDF]

Identifying and pursuing research priorities at the National Center for Complementary and Alternative Medicine
Richard L. Nahin
FASEB J 2005 19: 1209-1215. [Abstract] [Full Text] [PDF]

From conference abstract to full paper: differences between data presented in conferences and journals
Evangelos S. Rosmarakis, Elpidoforos S. Soteriades, Paschalis I. Vergidis, Sofia K. Kasiakou, and Matthew E. Falagas
FASEB J 2005 19: 673-680. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Toxicol Ind HealthHome page
L. Claxton
A review of conflict of interest, competing interest, and bias for toxicologists
Toxicology and Industrial Health, November 1, 2007; 23(10): 557 - 571.
[Abstract] [PDF]

Home page
 Am J Sports MedHome page
B. Reider
Passing the Headline Test
Am. J. Sports Med., November 1, 2007; 35(11): 1807 - 1808.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Federation of American Societies for Experimental Biology.